N-glycans are commonly found on various glycoproteins. While peptide N-glycosidase from Flavobacterium meningosepticum (PNGase F) is widely used to release virtually all types of N-glycans under denaturing conditions, Endo-beta -N-acetylglucosaminidases from the same bacterial species, including Endo F1, can be used under native conditions to specifically release particular types of N-glycans (1, 2). Because these glycosidases hydrolyze the chitobiose core ofN-glycans, the released glycan products will contain one GlcNAc residue at their reducing ends with the other GlcNAc residue remaining attached to an asparagine residue on the glycoprotein. Endo F1 specifically releases oligomannose and hybrid but not complex type N-glycans from glycoproteins (3, 4). This enzyme is also suitable to deglycosylate substrates under denaturing conditions and remains active on sulfated and core fucosylated N-glycans at reduced rates (4).
Recombinant F. meningosepticum Endo F1 Protein, CF
R&D Systems | Catalog # 5220-GH
Loading...
Key Product Details
- R&D Systems E. coli-derived Recombinant F. meningosepticum Endo F1 Protein (5220-GH)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
E. coli
Accession Number
Applications
Enzyme Activity
Loading...
Product Specifications
Source
E. coli-derived f. meningosepticum Endo-beta-N-acetylglucosaminidase F1/Endo F1 protein
Arg31-Trp339, with an N-terminal Met and 6-His tag
Accession # P36911
Arg31-Trp339, with an N-terminal Met and 6-His tag
Accession # P36911
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Met
Predicted Molecular Mass
35 kDa
SDS-PAGE
35 kDa, under reducing conditions
Activity
Measured by its ability to deglycosylate ribonuclease B under native conditions.
The DC50 is < 5 ng. The DC50 is defined as the amount of enzyme required to remove 50% of glycan on 1 μg of RNase B in 30 minutes at
37 °C.. Use of Recombinant F. meningosepticum
Endo F1 in the delycoslyation of other substrates may require alternative conditions for optimal performance.
The DC50 is < 5 ng. The DC50 is defined as the amount of enzyme required to remove 50% of glycan on 1 μg of RNase B in 30 minutes at
37 °C.. Use of Recombinant F. meningosepticum
Endo F1 in the delycoslyation of other substrates may require alternative conditions for optimal performance.
Formulation, Preparation, and Storage
5220-GH
| Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Endo-beta-N-acetylglucosaminidase F1/Endo F1
References
- Maley, F. et al. (1989) Anal. Biochem. 180:195.
- Tarentino, A.L. et al. (1985) Biochemistry. 24:4665.
- Tarentino, A.L. et al. (1992) J. Biol. Chem. 267:3868.
- Trimble, R.B. and Tarentino, A.L. (1991) J. Biol. Chem. 266:1646.
Alternate Names
CDC II-a, EndobetaNacetylglucosaminidase F1
UniProt
Additional Endo-beta-N-acetylglucosaminidase F1/Endo F1 Products
Product Documents for Recombinant F. meningosepticum Endo F1 Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant F. meningosepticum Endo F1 Protein, CF
For research use only
Related Research Areas
Customer Reviews for Recombinant F. meningosepticum Endo F1 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant F. meningosepticum Endo F1 Protein, CF and earn rewards!
Have you used Recombinant F. meningosepticum Endo F1 Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant F. meningosepticum Endo F1 Protein, CF (5220-GH):
Materials
- Assay Buffer: 50 mM Sodium Phosphate, pH 5.5
- Recombinant F. meningosepticum Endo-beta -N-acetylglucosaminidase F1/Endo F1 (rFmEndo F1) (Catalog # 5220-GH)
- Substrate: RNase B (Sigma, Catalog # R1153), 1 mg/mL stock in 10 mM Sodium Phosphate, pH 5.5
- 15% SDS-PAGE gel
- Reducing SDS-PAGE gel loading buffer
- Silver Staining reagents
- BioRad GS-800 densitometer (or equivalent)
- Dilute rFmEndo F1 to 2.5, 0.625, 0.156. 0.039, 0.0098, 0.0024, and 0.0006 μg/mL in Assay Buffer.
- Dilute Substrate to 100 μg/mL in Assay Buffer.
- Combine 10 μL rFmEndo F1 at each dilution with 10 μL of 100 μg/mL Substrate. Include a control containing 10 μL Assay Buffer and 10 μL of 100 μg/mL Substrate.
- Incubate the reaction and control at 37 °C for 30 minutes.
- Add 20 μL of reducing gel buffer to each reaction. Boil sample at 100 °C for 3 to 5 minutes before loading to gel.
- Load all of the sample (40 μL) per lane on a 15% gel. As a staining development control load 25 ng BSA.
- Perform electrophoresis.
- Stain gel with silver stain, stop stain development when 25 ng BSA becomes visible.
- Analyze % deglycosylation by densitometry.
- Determine the DC50 for rFmEndo F1 by plotting % Substrate deglycosylated vs. amount with 4-PL fitting.
- rFmEndo F1: 25, 6.25, 1.56, 0.39, 0.098, 0.024, and 0.006 ng
- Substrate: 1 µg
Loading...